| Thursday, December 10, 2020
| |
|
First Global Study of COVID-19 in Children With Cystic Fibrosis Reports Reassuring Outcomes
The Cystic Fibrosis Registry Global Harmonization Group, including the Cystic Fibrosis Foundation, recently published findings from the first global study on the impact of COVID-19 on children with cystic fibrosis in the Journal of Cystic Fibrosis. The manuscript reports on 105 children under the age of 18 with CF from 13 countries and concludes that COVID-19 is usually associated with mild illness in children without severe pre-existing lung disease, offering a significantly more reassuring outlook than originally anticipated at the start of the global pandemic.
| |
CF Foundation Funds 11 Laboratory Studies Exploring Underlying Factors that Impact COVID-19 As part of our comprehensive focus on fighting infections, the Foundation announced this week more than $2.7 million to support 11 laboratory studies that will explore the underlying factors that could impact COVID-19 outcomes in people with cystic fibrosis. Ultimately, insights gained from this body of research may be used to improve future treatments.
| |
CF Foundation Awards $1.7M in New Funding Under Path to a Cure Initiative
This week the Foundation announced $1.7 million in new research funding to drive progress on our Path to a Cure. The awards, to seven academic institutions and two companies, will support focused research into key scientific challenges associated with developing therapies to address the underlying cause of disease for all people with CF, regardless of their underlying mutation.
| |
CF Foundation Awards Up to $3.3M to Polyphor for Inhaled Version of Antibiotic to Treat Pseudomonas
We awarded up to $3.3 million to Polyphor to develop an inhaled version of murepavadin, an antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in people with cystic fibrosis. Funding will support a Phased 1b/2a clinical trial in adults with CF, which is expected to start in the fourth quarter of 2021 following a study in healthy volunteers.
| |
Together: Curing CF Recording is Now AvailableThe recording from our first national Breath of Life Celebration is now available. The event honored Preston W. Campbell III, MD, former president and CEO of the Foundation, for his transformative contributions over the past three decades in advancing research and care for people with CF. Watch to hear from members of the CF community, including Joe O’Donnell, Wells and Kelli Clark, and from entertainers and long-time supporters such as Lewis Black, Victoria Shaw, and Matt Rogers.
| |
|
|
|
|
